Lasa Supergenerics Ltd Stock Analysis

BSE: 540702 | NSE: LASA | Pharmaceuticals & Drugs | Small Cap

BSE Share Price Jan 25, 14:01
70.60 2.60 (3.82%)

DeciZen - Make an Informed Decision on Lasa Supergenerics

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation

Somewhat overvalued
P/E P/S EV/EBITDA

3. Price Trend

FAQ's

1. Is Lasa Supergenerics Ltd a good quality company?

Data is not available for this company.

2. Is Lasa Supergenerics Ltd undervalued or overvalued?

The key valuation ratios of Lasa Supergenerics Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Lasa Supergenerics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Lasa Supergenerics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Lasa Supergenerics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
ROCE % 0%11.2%9.7%-2.9%5.1%13.1%-
Value Creation Index NA-0.2-0.3-1.2-0.6-0.1-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 0199244170167202163
YoY Gr. Rt. %-NA22.5%-30.4%-1.4%21%-
Adj EPS 0501.55.4-5.215.6-0.6
YoY Gr. Rt. %-NA-98.9%-196.7%NA475.3%-
BVPS (₹) -60.210,983.351.346.134.839.135.6
Adj Net Profit 02.512.3-11.9422.7-3
Cash Flow from Ops. -0.4-340.440.713.641.3-
Debt/CF from Ops. -1-38.62.62.13.60.5-

CAGR

CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales NANA-6%21%
Adj EPS NANA1.3%475.3%
BVPS 00-8.712.3
Share Price - - 41.4% -16.2%

Key Financial Parameters

Performance Ratio Colour Code Guide
Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity % 06.612.8-10.73.215.1-1.7
Op. Profit Mgn % 02316.96.718.223.316.9
Net Profit Mgn % 01.35.1-72.411.2-1.6
Debt to Equity -1.22.10.90.80.30.10
Working Cap Days 066138206169118186
Cash Conv. Cycle 027533901867

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years -5.98%

Sales growth is not so good in last 4 quarters at -13.42%

Latest Financials - Lasa Supergenerics Ltd.

Standalone Consolidated
TTM EPS (₹) -0.6 -
TTM Sales (₹ Cr.) 163 -
BVPS (₹.) 35.6 -
Reserves (₹ Cr.) 104 -
P/BV 1.91 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 55.00 / 92.90
All Time Low / High (₹) 9.48 / 214.90
Market Cap (₹ Cr.) 277
Equity (₹ Cr.) 40.7
Face Value (₹) 10
Industry PE 38.1

Management X-Ray of Lasa Supergenerics :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *100.000.000.000.000.000.000.000.000.0043.23
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes

News

About Lasa Supergenerics Ltd

No data to display